Profile
MOTS TEM CON ARDT ELUT THMO
Company Name Motus GI Holdings, Inc. Tempus AI, Inc. Class A Common Stock Concentra Group Holdings Parent, Inc. Ardent Health Partners, LLC Elutia Inc. ThermoGenesis Holdings, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Market Cap $428.06K $6.91B $2.89B $2.43B $104.04M $3.01M
Employees 0.02K 0.00K 8.90K 18.60K 0.05K 0.03K
CEO Mr. Mark Pomeranz Mr. Eric P. Lefkofsky Mr. William Keith Newton Mr. Martin J. Bonick FACHE, M.H.A. Dr. C. Randal Mills Ph.D. Dr. Xiaochun Xu M.B.A., Ph.D.
Ratings
MOTS TEM CON ARDT ELUT THMO
Quant Rating Score 1 3 2
Quant Rating Strong Sell Neutral Sell
Trading
MOTS TEM CON ARDT ELUT THMO
Last Close $0.067 $41.92 $22.86 $17.24 $3.78 $0.19
High 52 $5.65 $43 $22.82 $17.3 $4.6 $1.39
Low 52 $0.04 $24.97 $22.57 $16.52 $3.75 $0.13
Price vs. 52 Week High -98.81 % -2.51 % 0.18 % -0.35 % -17.83 % -86.33 %
Price vs. 52 Week Low 67.5 % 67.88 % 1.28 % 4.36 % 0.8 % 46.15 %
Total Return
MOTS TEM CON ARDT ELUT THMO
1 Month Return 11.67 % 35.75 % 0 % 0 % 0 % -13.64 %
3 Month Return -17.28 % 0 % 0 % 0 % 0 % -72.06 %
6 Month Return -93.26 % 0 % 0 % 0 % 0 % -50 %
9 Month Return -83.66 % 0 % 0 % 0 % 0 % -82.88 %
YTD Return -94.75 % 0 % 0 % 0 % 0 % -68.39 %
1 Year Return -89.03 % 0 % 0 % 0 % 0 % -85.61 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
MOTS TEM CON ARDT ELUT THMO
Dividend Yield Percentage (TTM) - - - - - -
Dividend Paid and Capex Coverage Ration (TTM) -132.54 % - - - - -3.68 %
Dividend Per Share (TTM) - - - - - -
Payout Ratio (TTM) - - - - - -
Growth
MOTS TEM CON ARDT ELUT THMO
Asset Growth -59.07 % -42.06 %
Gross Profit Growth -188.48 % -28.75 %
Revenue Growth -46.11 % -9.9 %
Revenue 3 Year -56.95 % -94.29 %
Revenue 5 Year -44.77 % -98.31 %
Revenue 10 Year - -99.93 %
EBIT Growth 33.3 % -39.03 %
Net Income Growth 28.88 % -59.49 %
Net Income 3 Yeari Growth Per Share 91.32 % 93.52 %
Net Income 5 Yeari Growth Per Share 96.4 % 99.22 %
Net Income 10 Yeari Growth Per Share 86.23 % 99.76 %
Operating Income Growth 33.3 % -39.03 %
Operating Cash Flow Growth (CFG) 34.77 % 48.91 %
Operating 3 Year CFG 91.13 % 98.48 %
Operating 5 Year CFG 95.24 % 99.08 %
Operating 10 Year CFG 85.16 % 99.95 %
EPS Growth 81.04 % 62.89 %
EPS Diluted Growth 81.04 % 62.89 %
Book Value Per Share -75.93 % -109.03 %
Share Holder 3 Year Equity Growth Per Share -96.85 % -101.69 %
Share Holder 5 Year Equity Growth Per Share -99.1 % -100.34 %
Share Holder 10 Year Equity Growth Per Share 104.63 % -100 %
Dividend Per Share Growth - -
Dividend 3 Year Growth Per Share - -
Dividend 5 Year Growth Per Share - -
Dividend 10 Year Growth Per Share - -
Debt Growth -78.42 % 1.84 %
Free Cash Flow Growth 35.01 % 29.01 %
Updated On 31 Dec 2023 31 Dec 2023
Profitability
MOTS TEM CON ARDT ELUT THMO
Gross Profit Margin TTM -48.93 % 21.1 %
Return on Assets TTM -120.04 % -146.18 %
Return on Equity TTM -1466.82 % -762.31 %
Return on Capital Employed TTM -254.83 % -455.52 %
Net Income Per EBT TTM 100 % 93.69 %
EBT Per Ebit TTM 88.59 % 193.77 %
EBIT Per Revenue TTM -2927.83 % -84.52 %
Cash Flow To Debt Ratio TTM -353.36 % -47.72 %
Receivables Turnover TTM 4.04 8.36
Payables Turnover TTM - 7.67
Inventory Turnover TTM 2.14 6.09
Fixed Asset Turnover TTM 31.08 % 175.36 %
Asset Turnover TTM 4.63 % 95.27 %
Operating Cash Flow Per Share TTM -1 -0.9
Free Cash Flow Per Share TTM -1.01 -1.14
Cash Per Share TTM 57.4 % 29.21 %
Operating Cash Flow Sales Ratio TTM -2634.56 % -37.58 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.75 % 127.19 %
Cash Flow Coverage Ratios TTM -353.36 % -47.72 %
Price To Free Cash Flows Ratio TTM -0.05 -0.66
Price To Operating Cash Flows Ratio TTM -0.07 -0.21
Price Cash Flow Ratio TTM -0.07 -0.21
Income Statement (TTM)
MOTS TEM CON ARDT ELUT THMO
Revenue $0B $0.01B
Gross Profit $-0B $0B
Gross Profit Ratio -184.48% 20.44%
EBITDA $-0.01B $-0.01B
Net Income $-0.01B $-0.02B
EPS Diluted -15.89 -7.59
Balance Sheet (MRQ)
MOTS TEM CON ARDT ELUT THMO
Long Term Debt $0B $0B
Total Liabilities $0B $0.01B
Total Equity $0B $-0B
Total Investments $0B $0B
Total Debt $0B $0.01B
Total Assets $0.01B $0.01B
Cash Flow Statement (TTM)
MOTS TEM CON ARDT ELUT THMO
Net Income $-0.01B $-0.02B
Inventory $0B $0B
Dividends Paid $0B $0B
Operating Cash Flow $-0.01B $-0B
Capital Expenditure $-0B $-0B
Related Stocks
Ticker Name Price
ARDT Ardent Health Partners, LLC 17.24
CON Concentra Group Holdings Parent, Inc. 22.86
ELUT Elutia Inc. 3.78
TEM Tempus AI, Inc. Class A Common Stock 41.92
THMO ThermoGenesis Holdings, Inc. 0.19
ETFs With Exposure to MOTS
Ticker ETF Name Weight Percentage Price
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 119.77
VXF Vanguard Extended Market Index Fund 0 178.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
Unlock